Mr Lewis is the vice president and general manager of Arcutis’ Canadian affiliate. He joined Arcutis in August 2021 as head of Canadian operations and was responsible for building out the local team that successfully launched our steroid-free cream for plaque psoriasis into a crowded marketplace. Previously, Mr Lewis spent seven years at Celgene where he was the Canadian business unit director for inflammation and immunology with his role being expanded to also include hematology and oncology. At Celgene he was responsible for building out the team that launched Otezla®, among other drugs. Prior to that, Mr Lewis spent 12 years at Amgen Canada in positions of increasing responsibility, culminating as business unit director, inflammation, where he was accountable for Enbrel® sales and marketing. Mr Lewis started his career as a sales representative at Merck and Janssen Canada. He earned a BSc in Pharmacology and Toxicology at Western University and a MSc in Toxicology from the University of Guelph.
Download our corporate fact sheet.
Download